GI-Safer Formulation of Indomethacin for use in Preterm Neonates
PLx Opco Inc. · Department of Health and Human Services
Phase II2012$1,118,398
DESCRIPTION (provided by applicant): This application is for a SBIR Phase II grant. One of the major causes of morbidity and mortality of low birth weight neonates relates to injury, inflammation, perforation and obstru…